Abstract:Abstract Background Phosphorylation modification of BCL2 is involved in receptor activator of nuclear factor-κB ligand (RANKL)-induced autophagy of osteoclast precursors (OCPs) and osteoclastogenesis. As an antiapoptotic molecule, the role of BCL2 phosphorylation in osteoclastogenesis is unknown. This study aimed to explore how BCL2 phosphorylation at specific sites regulates osteoclastogenesis. Methods We first examined the effects of RANKL on BCL2 phosphorylation at different sites (Ser70 and Ser87) in OCPs. In vivo, transgenic mice overexpressing RANKL (Tg-hRANKL mice) were used to observe the effects of RANKL on phosphorylated BCL2 at different sites in OCPs of trabecular bone. Subsequently, using site-directed mutagenesis, we observed the respective effect of BCL2 mutations at different phosphorylation sites in OCPs on osteoclastogenesis, apoptosis, autophagy and the affinity between BCL2 and Beclin1/BAX under RANKL intervention. Results RANKL promoted BCL2 phosphorylation at the Ser70 (S70) site, but not the Ser87 (S87) site, in OCPs. Moreover, Tg-hRANKL mice had stronger BCL2 phosphorylation capacity at S70, not S87, in the OCPs of trabecular bone than wild-type mice in the same nest. Furthermore, BCL2 mutation at S70, not S87, inhibited RANKL-induced osteoclast differentiation and bone resorption activity. In addition, BCL2 mutation at S70 promoted OCP apoptosis, while BCL2 mutation at S87 showed the opposite effect. Remarkably, the BCL2 mutation at S70, not S87, inhibited OCP autophagic activity. Furthermore, BCL2 mutation at S70 enhanced the coimmunoprecipitation of BCL2 and Beclin1, whereas BCL2 mutation at S87 enhanced the coimmunoprecipitation of BCL2 and BAX in OCPs. More importantly, OCP autophagy, osteoclast differentiation and resorption pits inhibited by BCL2 mutation at S70 could be reversed by Beclin1 upregulation with TAT-Beclin1. Conclusion RANKL activates OCP autophagy through BCL2 phosphorylation at S70, thereby promoting osteoclastogenesis, which indicates that the inactivation of BCL2 at S70 in OCPs may be a therapeutic strategy for pathological bone loss.

Phosphorylation of Bcl10 Negatively Regulates T-cell Receptor-Mediated NF-kappaB Activation.

Bcl10 can promote survival of antigen-stimulated B lymphocytes

Bcl10 Plays A Critical Role in Nf-Kappa B Activation Induced by G Protein-Coupled Receptors

The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.

Bcl10 Phosphorylation-Dependent Droplet-Like Condensation Positively Regulates DNA Virus-Induced Innate Immune Signaling

Specific effects of BCL10 Serine mutations on phosphorylations in canonical and noncanonical pathways of NF-κB activation following carrageenan

BCL10 Mediates Lipopolysaccharide/toll-Like Receptor-4 Signaling Through Interaction with Pellino2.

Phosphorylation-induced flexibility of proto-oncogenic Bcl3 regulates transcriptional activation by NF-κB p52 homodimer

Bcl10 is required for the development and suppressive function of Foxp3+ regulatory T cells

Characterization of Bcl10 as a potential transcriptional activator that interacts with general transcription factor TFIIB.

Bcl 10 plays a critical role in NF-B activation induced by G protein-coupled receptors

The Role of BCL11B in Regulating the Proliferation of Human Naive T Cells.

A direct interaction between the adaptor protein Cbl-b and the kinase zap-70 induces a positive signal in T cells.

Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis

NF-κB Downregulates Cbl-b Through Binding and Suppressing Cbl-b Promoter in T Cell Activation.

B-cell Receptor-Mediated NFATc1 Activation Induces IL-10/STAT3/PD-L1 Signaling in Diffuse Large B-cell Lymphoma

BCL11B and the NuRD complex cooperatively guard T-cell fate and inhibit OPA1-mediated mitochondrial fusion in T cells

Cbl Promotes Ubiquitination of the T Cell Receptor Ζ Through an Adaptor Function of Zap-70

Dual Regulation of T Cell Receptor-mediated Signaling by Oncogenic Cbl Mutant 70Z*

BCL-6 negatively regulates expression of the NF-kappaB1 p105/p50 subunit

Dual Regulation of T Cell Receptor-mediated Signaling by Oncogenic Cbl Mutant 70Z